FrancophonIA/ELRC3.0 huggingface dataset:
English: Reproduction toxicity studies with timolol showed delayed foetal ossification in rats with no adverse effects on postnatal development (at 50 mg/kg/day or 3,500 times the daily clinical dose of 14 g/kg/day) and increased foetal resorptions in rabbits (at 90 mg/kg/day or 6,400 times the daily clinical dose).
Croatian: Istraživanja reprodukcijske toksičnosti timolola pokazala su odgođeno okoštavanje u fetusa štakora, bez štetnih učinaka na postnatalni razvoj (pri 50 mg/kg/dan ili dozi 3500 puta većoj od dnevne kliničke doze koja iznosi 14 g/kg/dan), kao i pojačanu fetalnu resorpciju u kunića (pri 90 mg/kg/dan, tj. dozi 6400 puta većoj od kliničke doze).
English: Dose-related decreases in foetal weights were observed in pups of dams receiving brinzolamide orally ranging from a slight decrease (about 5-6%) at 2 mg/kg/day to nearly 14% at 18 mg/kg/day.
Croatian: O dozi ovisno smanjenje težine fetusa uočeno je u ženki koje su peroralno primale brinzolamid, a kretalo se od blagog smanjenja (oko 5-6%) pri dozi od 2 mg/kg/dan do gotovo 14% pri dozi od 18 mg/kg/dan.
English: Beta-blockers may also mask the signs of hyperthyroidism.
Croatian: Beta-blokatori mogu prikriti znakove hipertireoze.
English: In addition, signs and symptoms of beta-blockade (e.g. bradycardia, hypotension, respiratory distress and hypoglycaemia) have been observed in the neonate when beta-blockers have been administered until delivery.
Croatian: Dodatno, znakovi i simpotmi betablokade (npr. bradikardija, hipotenzija, respiratorni distres i hipoglikemija) zabilježeni su kod novorođenčeta kada su beta blokatori bili primjenjivani do poroda.
English: • General side effects: heart rate decreased, taste disturbances.
Croatian: • Opće nuspojave: usporeni srčani otkucaji, poremećaj okusa.
English: The concomitant administration of eye drops containing brinzolamide and oral carbonic anhydrase inhibitors is not recommended.
Croatian: Istodobna primjena kapi za oko koje sadrže brinzolamid i oralnih inhibitora karboanhidraze se ne preporučuje.
English: 1, psoriasiform rash or exacerbation of psoriasis
Croatian: 1, psorijatični osip ili egzacerbacija psorijaze
English: Other medicines and AZARGA Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Croatian: Obavijestite svog liječnika ili ljekarnika ako primjenjujete, nedavno ste primijenili ili biste mogli primijeniti bilo koje druge lijekove.
English: 1, blood lactate dehydrogenase increased adverse reactions observed for Azarga additional adverse reactions observed with timolol monotherapy additional adverse reactions observed with brinzolamide monotherapy
Croatian: 1, povišena laktat dehidrogenaza u krvi nuspojave zabilježene s Azargom dodatne nuspojave zabilježene kod primjene timolola kao monoterapije dodatne nuspojave zabilježene kod primjene brinzolamida kao monoterapije
English: 3, nightmare
Croatian: 3, noćne more nervoza
English: For ocular use.
Croatian: Za oko.
English: Nervous system disorders Common: dysgeusia Not known: cerebral ischaemia
Croatian: Često: disgeuzija1 Nepoznato: cerebralna ishemija
English: No studies have been conducted with AZARGA or with timolol 5 mg/ml eye drops in patients with hepatic or renal impairment.
Croatian: Nisu provedena ispitivanja AZARGE ni timolola 5 mg/ml kapi za oko u bolesnika s oštećenom jetrenom ili bubrežnom funkcijom.
English: AZARGA contains brinzolamide, a carbonic anhydrase inhibitor and, although administered topically, is absorbed systemically.
Croatian: AZARGA sadrži brinzolamid koji je inhibitor karboanhidraze i, premda se primjenjuje lokalno, apsorbira se sustavno.
English: 1, systemic allergic reactions including angioedema,
Croatian: 2, anafilaktički šok 1, sistemske alergijske reakcije uključujući angioedem 2, lokalizirani i generalizirani osip
English: Epidemiological studies have not revealed malformative effects but show a risk for intra uterine growth retardation when beta-blockers are administered by the oral route.
Croatian: Epidemiološka ispitivanja nisu otkrila učinak na pojavu malformacija ali su pokazala rizik za intrauterini zastoj rasta kod peroralne primjene beta-blokatora.
English: • The other ingredients are benzalkonium chloride (see section 2 ‘AZARGA contains benzalkonium'), carbopol 974P, disodium edetate, mannitol (E421), purified water, sodium chloride, tyloxapol, hydrochloric acid and/or sodium hydroxide.
Croatian: • Drugi sastojci su benzalkonijev klorid (vidjeti dio 2. „AZARGA sadrži benzalkonijev klorid“), karbopol (974P), dinatrijev edetat, manitol (E421), pročišćena voda, natrijev klorid, tiloksapol, kloridna kiselina i/ili natrijev hidroksid.
English: If you are changing from another eye drop medicine used to treat glaucoma to AZARGA, you should stop using the other medicine and start using AZARGA the following day.
Croatian: U slučaju da zamjenjujete druge kapi za oko za liječenje glaukoma AZARGOM, morate prekinuti primjenu drugog lijeka te započeti s primjenom AZARGE sljedeći dan.
English: • Effects in the eye: corneal disorder, sensitivity to light, increased tear production, eyelid crusting
Croatian: • Nuspojave na oku: poremećaj rožnice, osjetljivost na svjetlost, pojačano stvaranje suza,
English: Rare side effects (may affect up to 1 in 1,000 people)
Croatian: Rijetke nuspojave (mogu se pojaviti u manje od 1 na 1000 osoba)
English: 2, hypertension
Croatian: 2, hipertenzija
English: • The active substances are brinzolamide and timolol.
Croatian: • Djelatne tvari su brinzolamid i timolol.
English: 1, ptosis
Croatian: 1, ptoza
English: • Shake well before use.
Croatian: • Bočicu dobro protresite prije uporabe.
English: Beta-blocking ophthalmological preparations may block systemic beta-agonist effects e.g. of adrenaline.
Croatian: Beta-blokatori lokalno primijenjeni u oko mogu blokirati sustavne beta-agonističke učinke npr. adrenalina.
English: Potentiated systemic beta-blockade (e.g. decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g. quinidine, fluoxetine, paroxetine) and timolol.
Croatian: Prijavljena je pojačana sustavna beta blokada (npr. usporena srčana frekvencija, depresija) pri kombiniranoj primjeni inhibitora CYP2D6 (npr. kinidina, fluoksetina, paroksetina) i timolola.
English: AZARGA contains brinzolamide, a sulphonamide.
Croatian: AZARGA sadrži brinzolamid koji je sulfonamid.
English: Similar studies in rats resulted in slightly reduced ossification of skull and sternebrae of foetuses of dams receiving brinzolamide at doses of 18 mg/kg/day (642 times the recommended daily clinical dose), but not 6 mg/kg/day.
Croatian: Slična istraživanja u štakora pokazala su malo slabije okoštavanje lubanje i sternuma fetusa ženki koje su primale brinzolamid u dozi od 18 mg/kg/dan (642 puta većoj od preporučene dnevne kliničke doze), ali ne i ženki koje su primale dozu od 6 mg/kg/dan.
English: The hypertensive reaction to sudden withdrawal of clonidine can be potentiated when taking betablockers.
Croatian: Hipertenzijska reakcija izazvana naglim prestankom uzimanja klonidina može se pojačati pri uzimanju beta-blokatora.
English: Listed adverse reactions include reactions seen within the class of ophthalmic beta-blockers.
Croatian: Navedene nuspojave uključuju reakcije koje se javljaju unutar skupine beta blokatora lokalno primijenjenih u oko.
English: 3, increased blood chloride Immune system disorders Not known: anaphylaxis
Croatian: 3, povišena razina klorida u krvi Poremećaji imunološkog sustava Nepoznato: anafilaksija
English: Uncommon: cough Rare: oropharyngeal pain
Croatian: Manje često: kašalj Rijetko: orofaringealna bol
English: Brinzolamide and N-desethyl-brinzolamide are the predominant components found in the urine along with trace levels (<1%) of the N-desmethoxypropyl and O-desmethyl metabolites.
Croatian: Predominantne komponente u urinu su brinzolamid i N-dezetil-brinzolamid, zajedno s N-dezmetoksipropilnim i O-dezmetilnim metabolitima koji se nalaze u tragovima (<1%).
English: Nasolacrimal occlusion or gently closing the eyelid after instillation may help reduce the occurrence of this effect (see section 4.2).
Croatian: Učestalost tog učinka može se smanjiti nazolakrimalnom okluzijom ili blagim zatvaranjem vjeđe nakon ukapavanja (vidjeti dio 4.2).
English: There is potential for an additive effect on the known systemic effects of carbonic anhydrase inhibition in patients receiving an oral carbonic anhydrase inhibitor and AZARGA.
Croatian: Postoji mogućnost dodatnog učinka na poznate sustavne učinke inhibitora karboanhidraze kod bolesnika koji uzimaju oralni inhibitor karboanhidraze i AZARGU.
English: Contains: benzalkonium chloride, mannitol (E421), carbopol 974P, tyloxapol, disodium edetate, sodium chloride, hydrochloric acid and/or sodium hydroxide (to adjust pH), purified water.
Croatian: Sadrži: benzalkonijev klorid, manitol (E421), karbopol 974P, tiloksapol, dinatrijev edetat, natrijev klorid, kloridnu kiselinu i/ili natrijev hidroksid (za podešavanje pH), pročišćenu vodu.
English: AZARGA contains a preservative (benzalkonium chloride) which may be absorbed by soft contact lenses and may change the colour of the contact lenses.
Croatian: AZARGA sadrži konzervans (benzalkonijev klorid) kojeg mogu apsorbirati meke kontaktne leće zbog čega se može promijeniti njihova boja.
English: Tell your doctor if you are taking or intent to take medicines to lower blood pressure like parasympathomimetics and guanetidine, or other heart medicines including quinidine (used to treat heart conditions and some types of malaria), amiodarone or other medicines to treat heart rhythm disorders and glycosides to treat heart insufficiency.
Croatian: Obavijestite svog liječnika ako primjenjujete ili biste mogli primijeniti lijekove za snižavanje krvnog tlaka poput parasimpatomimetika i gvanetidina, ili druge lijekove za srce uključujući kinidin (koristi se za liječenje srčanih bolesti i nekih tipova malarije), amiodaron ili druge lijekove za liječenje poremećaja srčanog ritma i glikozide za liječenje srčane insuficijencije, lijekove za liječenje šećerne bolesti ili za liječenje želučanih čireva, lijekove protiv gljivica i virusa, antibiotike, ili antidepresive kao što su fluoksetin i paroksetin.
English: Pull down your eyelid with a clean finger, until there is a ‘pocket' between the eyelid and your eye.
Croatian: Čistim prstom povucite donju vjeđu, tako da se između vjeđe i oka stvori
English: Write down the date of opening on the bottle label and carton label in the space provided.
Croatian: Na naljepnici bočice i kutije u predviđeni prostor napišite datum kada ste je otvorili.
English: • Muscular: generalised back, joint, or muscle pain not caused by exercise, muscle spasms, pain in extremities, muscle weakness/tiredness, increases in the signs and symptoms of myasthenia gravis (muscle disorder).
Croatian: • Mišići: opća bol, bol u leđima, zglobovima ili mišićima koja nije uzrokovana vježbanjem, grčevi mišića, bol u udovima, mišićna slabost/umor, pogoršanje znakova i simptoma mijastenije gravis (mišićni poremećaj).
English: 2, conjunctivitis
Croatian: 2, konjunktivitis
English: In a twelve-month, controlled clinical trial in patients with open-angle glaucoma or ocular hypertension who, in the investigator's opinion could benefit from a combination therapy, and who had baseline mean IOP of 25 to 27 mmHg, the mean IOP-lowering effect of AZARGA dosed twice daily was 7 to 9 mmHg.
Croatian: U 12-mjesečnom kontroliranom kliničkom istraživanju u bolesnika s glaukomom otvorenog kuta ili s očnom hipertenzijom koji su, prema ocjeni ispitivača, mogli imati koristi od kombiniranog liječenja, i u kojih je srednji očni tlak prije početka liječenja bio 25 do 27 mmHg, primjenom AZARGE dvaput na dan srednji se očni tlak snizio za 7 do 9 mmHg.
English: AZARGA contains two active substances: brinzolamide and timolol maleate.
Croatian: AZARGA sadrži dvije djelatne tvari: brinzolamid i timololmaleat.
English: • if you have problems with your kidneys.
Croatian: • Ako imate poteškoća s bubrezima.
English: • if you have a history of atopy (a tendency to develop an allergic reaction) and severe allergic reactions you may be more sensitive to developing an allergic reaction whilst using AZARGA
Croatian: • ukoliko ste ranije imali atopiju (sklonost razvoju alergijskih reakcija) i jake alergijske reakcije,
English: Benzalkonium chloride
Croatian: Benzalkonijev klorid
English: Studies have not been performed to evaluate the effect of topical ocular administration of Azarga on human fertility.
Croatian: Nisu provedena ispitivanja procjene učinka topikalne okularne primjene AZARGE na plodnost u ljudi.
English: The potential for interactions must be considered in patients receiving AZARGA.
Croatian: U bolesnika koji uzimaju AZARGU mora se razmotriti mogućnost interakcija.
English: • Skin: rash, skin redness or inflammation, abnormal or decreased skin sensation, hair loss, rash with white silvery coloured appearance (psoriasiform rash) or worsening of psoriasis.
Croatian: • Koža: osip, crvenilo ili upala kože, nenormalna ili smanjena osjetljivost kože, ispadanje kose, bjelkasto srebrnkasti osip (psorijatični osip) ili pogoršanje psorijaze.
English: Following topical ocular administration, brinzolamide and timolol are absorbed through the cornea and into the systemic circulation.
Croatian: Nakon lokalne primjene u oko brinzolamid i timolol se apsorbiraju kroz rožnicu i ulaze u sustavnu cirkulaciju.
English: N-desethyl brinzolamide is a major metabolite of brinzolamide formed in humans, which also binds to CA-I in the presence of brinzolamide and accumulates in RBCs.
Croatian: Glavni metabolit brinzolamida u čovjeka je N-dezetil-brinzolamid, koji se također veže na CA-I u prisutnosti brinzolamida i koji se nakuplja u eritrocitima.
English: • Heart and circulation: changes in rhythm or rate of the heartbeat, slow heart rate, palpitations, a type of heart rhythm disorder, abnormal increase in heart rate, chest pain, reduced heart function, heart attack, increased blood pressure, reduced blood supply to the brain, stroke, oedema (fluid build up), congestive heart failure (heart disease with shortness of breath and swelling of the feet and legs due to fluid build up), swelling of the extremities, low blood pressure, discoloration of the fingers, toes, and occasionally other areas of the body (Raynaud's phenomenon), cold hands and feet.
Croatian: • Srce i cirkulacija: promjene ritma ili brzine srčanih otkucaja, usporeni srčani otkucaji, osjećaj lupanja srca, poremećaj srčanog ritma, nenormalno ubrzani srčani otkucaji, bol u prsnom košu, oslabljena funkcija srca, srčani udar, povišeni krvni tlak, smanjena opskrba krvi u mozak, moždani udar, edem (nakupljanje tekućine), kongestivno zatajenje srca (bolest srca koju prati nedostatak zraka i oticanje stopala i nogu zbog nakupljanja tekućine), oticanje udova, nizak krvni tlak, promjena boje kože na prstima ruke, nožnim prstima i povremeno drugim dijelovima tijela (Raynaudov fenomen), hladne ruke i stopala.
English: There is a potential for an additive effect on the known systemic effects of carbonic anhydrase inhibition in patients receiving an oral carbonic anhydrase inhibitor and brinzolamide eye drops.
Croatian: Postoji mogućnost aditivnog učinka na poznate sustavne učinke inhibitora karboanhidraze u bolesnika koji primaju oralne inhibitore karboanhidraze i brinzolamid kapi za oko.
English: In a six-month, controlled clinical study in patients with open-angle glaucoma or ocular hypertension and baseline mean IOP of 25 to 27 mmHg, the mean IOP-lowering effect of AZARGA dosed twice daily was 7 to 9 mmHg, and was up to 3 mmHg greater than that of brinzolamide 10 mg/ml dosed twice daily and up to 2 mmHg greater than that of timolol 5 mg/ml dosed twice daily.
Croatian: 6-mjesečnom kontroliranom kliničkom istraživanju u bolesnika s glaukomom otvorenog kuta ili s očnom hipertenzijom u kojih je srednji očni tlak prije početka liječenja bio 25 do 27 mmHg, primjenom AZARGE dvaput na dan srednji se očni tlak snizio za 7 do 9 mmHg, što je bilo za do 3 mmHg više nego pri primjeni brinzolamida 10 mg/ml dvaput na dan i za do 2 mm Hg više nego pri primjeni timolola 5 mg/ml dvaput na dan.
English: If affected take care when driving or using machines.
Croatian: Dogodi li Vam se to, budite oprezni pri upravljanju vozilima i strojevima.
English: • Respiratory: Constriction of the airways in the lungs (predominantly in patients with preexisting disease) shortness of breath or difficulty breathing, cold symptoms, chest congestion, sinus infection, sneezing, stuffy nose, dry nose, nose bleeds, asthma, throat irritation.
Croatian: • Dišni sustav: Konstrikcija (suženje) dišnih puteva u plućima (uglavnom kod bolesnika s već postojećom bolesti), nedostatak zraka ili otežano disanje, simptomi prehlade, zastoj krvi u prsnom košu, infekcija sinusa, kihanje, začepljen nos, suhoća nosa, krvarenje iz nosa, astma, nadražaj grla.
English: Due to the beta-adrenergic blocking component, timolol, the same types of cardiovascular, pulmonary and other adverse reactions seen with systemic beta-adrenergic blocking agents may occur.
Croatian: Zbog timolola, koji je beta-adrenergički blokator, mogu se javiti jednake vrste kardiovaskularnih, plućnih i drugih nuspojava kao i pri sustavnoj primjeni beta-adrenergičkih blokatora.
English: Common side effects (may affect up to 1 in 10 people)
Croatian: Česte nuspojave (mogu se pojaviti u manje od 1 na 10 osoba)
English: AZARGA is absorbed systemically and therefore this may occur with topical administration.
Croatian: AZARGA se apsorbira sustavno te se stoga ove nuspojave mogu javiti i kod lokalne primjene.
English: If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart.
Croatian: U slučaju primjene više od jednog lijeka za lokalnu primjenu u oko, vremenski razmak između primjene lijekova mora biti najmanje 5 minuta.
English: INFORMATION IN BRAILLE
Croatian: 16 PODACI NA BRAILLEOVOM PISMU
English: • Nervous system and general disorders: depression, nightmares, memory loss, headache, nervousness, irritability, tiredness, shaking, feeling abnormal, fainting, dizziness, drowsiness, generalised or severe weakness, unusual sensations like pins and needles.
Croatian: • Živčani sustav i opći poremećaji: depresija, noćne more, gubitak pamćenja, glavobolja, nervoza, razdražljivost, umor, drhtavica, nenormalan osjećaj, nesvjestica, omaglica, omamljenost, opća ili izrazita slabost, osjećaj probadanja kao tankim oštrim predmetima sličnim iglama.
English: • Bring the bottle tip close to the eye. Use the mirror if it helps.
Croatian: Koristite se ogledalom, ako Vam to pomaže.
English: 3, tinnitus
Croatian: 3, tinitus
English: Mydriasis resulting from concomitant use of ophthalmic beta-blockers and adrenaline (epinephrine) has been reported occasionally.
Croatian: Povremeno je zabilježena midrijaza kao rezultat istodobne primjene oftalmičkih beta-blokatora i adrenalina (epinefrina).
English: 1, eye pruritus 1, foreign body sensation in eyes 1, ocular hyperaemia
Croatian: 1, svrbež oka osjećaj stranog tijela u očima
English: • Effects in the eye: eye allergy, disturbance of vision, damage to the optic nerve, increased pressure in eye, deposits on the eye surface, decreased eye sensation, inflammation or infection of the conjunctiva (white of the eye), abnormal, double or reduced vision, increased pigmentation of the eye, growth on surface of eye, eye swelling, sensitivity to light, decreased growth or number of eyelashes, drooping of the upper eyelids (making the eye stay half closed), inflammation of the eyelid and eye lid glands, inflammation in the cornea and detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity.
Croatian: • Nuspojave na oku: alergija oka, poremećaj vida, oštećenje vidnog živca, povišeni tlak u oku, depoziti (talozi) na površini oka, smanjena osjetljivost oka, upala ili infekcija očne spojnice (na bijelom dijelu oka), nenormalan, dvostruki ili oslabljeni vid, pojačana pigmentacija oka, izraslina na površini oka, oticanje oka, osjetljivost na svjetlo, sporiji rast ili smanjeni broj trepavica, spuštenost gornjih vjeđa (poluzatvoreno oko), upala vjeđa i upala žlijezda vjeđa, upala rožnice i odvajanje sloja ispod mrežnice (žilnice) koji sadrži krvne žile nakon filtracijske operacije što može uzrokovati poremećaj vida, smanjena osjetljivost rožnice.
English: Dysgeusia (bitter or unusual taste in the mouth following instillation) was a frequently reported systemic adverse reaction associated with the use of AZARGA during clinical trials.
Croatian: Često prijavljivana sustavna nuspojava povezana s primjenom AZARGE u kliničkim ispitivanjima bila je disgeuzija (gorak ili neuobičajeni osjet u ustima nakon ukapavanja).
English: 1, erythema
Croatian: 1, eritem
English: , nervousness
Croatian: , palpitacije
English: 1, asthma
Croatian: 1, astma epistaksa
English: 3, epistaxis bronchial hyperactivity
Croatian: 1, bronhalna hiperaktivnost
English: How to use AZARGA
Croatian: Kako primjenjivati AZARGU
English: • if you have liver problems.
Croatian: • Ako imate poteškoća s jetrom.
English: The affinity of brinzolamide and metabolite to RBC and tissue CA results in low plasma concentrations.
Croatian: Zbog visokog afiniteta brinzolamida i njegova metabolita za CA u eritrocitima i tkivima, koncentracije u plazmi su mu male.
English: AZARGA contains benzalkonium chloride which may cause eye irritation and is known to discolour soft contact lenses.
Croatian: AZARGA sadrži benzalkonijev klorid koji može nadražiti oko, a poznato je i da mijenja boju mekih kontaktnih leća.
English: 3, back pain
Croatian: 3, bol u leđima
English: This may cause similar adverse reactions as seen with systemic beta-blocking medicinal products.
Croatian: To može uzrokovati slične nuspojave koje se javljaju kod primjene sustavnih beta blokatora.
English: Pharmacotherapeutic group: Ophthalmologicals, Antiglaucoma preparation and miotics ATC code: S01ED51
Croatian: Farmakoterapijska skupina: Oftalmici, Pripravci za liječenje glaukoma i miotici.
English: • Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper.
Croatian: • Vrhom bočice ne dotičite oko, vjeđu, okolno područje ni ostale površine.
English: AZARGA 10 mg/ml + 5 mg/ml eye drops, suspension
Croatian: AZARGA 10 mg/ml + 5 mg/ml kapi za oko, suspenzija
English: 3, peripheral oedema medication residue
Croatian: 3, periferni edem 3, zaostajanje lijeka
English: 3, pharyngitis
Croatian: 3, faringitis
English: The same type of adverse reactions attributable to oral carbonic anhydrase inhibitors may occur with topical administration.
Croatian: Iste vrste nuspojava koje se pripisuju peroralno primijenjenim inhibitorima karboanhidraze moguće su i pri njihovoj lokalnoj primjeni.
English: The dose should not exceed one drop in the affected eye (s) twice daily.
Croatian: Doza od po jedne kapi dvaput na dan u oko koje se liječi ne smije se prekoračiti.
English: Approximately 20% of a timolol dose is excreted in the urine unchanged and the remainder excreted in urine as metabolites.
Croatian: Približno 20% doze timolola izlučuje se u urin u nepromijenjenu obliku, a ostatak se u urin izlučuje u obliku metabolita. t1/2 timolola u plazmi nakon primjene AZARGE iznosi 4,8 sati.
English: Choroidal detachment has been reported with administration of aqueous suppressant therapy (e.g. timolol, acetazolamide) after filtration procedures.
Croatian: Odvajanje žilnice zabilježeno je kod pacijenata koji nakon filtracijske operacije koriste terapiju za supresiju stvaranja očne vodice (npr. timolol, acetazolamid).
English: 2, decreased libido
Croatian: 3, smanjen libido
English: No effects on male or female fertility are anticipated from the use of AZARGA.
Croatian: Ne očekuje se učinak primjene AZARGE na plodnost kod muškaraca ili žena.
English: 3, oral hypoaesthesia
Croatian: 3, oralna hipoestezija
English: AZARGA 10 mg/ml + 5 mg/ml eye drops, suspension brinzolamide/timolol
Croatian: AZARGA 10 mg/ml + 5 mg/ml kapi za oko, suspenzija brinzolamid/timolol